Genetically deletion of USP13 or MKK3 suppressed CRC cell proliferation, migration in vitro and tumor formation in vivo, effects that were synergistically enhanced by the pharmacological inhibition of p38 signaling. The gene discussed is MAP2K3; the disease is neoplasm.